Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Nov 14, 2023
Episode
186
Soundcloud
Share
Lung Cancer Considered host Dr. Narjust Florez leads an informed discussion on the AEGEAN Trial, which explored neoadjuvant durvalumab plus chemotherapy followed by adjuvant durvalumab in patients with resected NSCLC.
Guest
Tercia Reis
MD
Thoracic Medical Oncologist
Grupo Oncoclinicas in Salvador
